Home › Inflammatory Bowel Disease › NCT06315179

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation

Who can join

Ages 6 to 21 · All sexes

Inclusion Criteria:

* Suspected diagnosis of CD (Crohn's Disease), UC (Ulcerative Colitis) or Indeterminate colitis (IC)

Exclusion Criteria:

* Evidence of Other Complicating Medical Issues:
* Other serious medical conditions, such as neurological, liver, kidney, or systemic disease
* Pregnancy
* Tobacco, alcohol, or illicit drug abuse

About the study

This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation and a control cohort of pediatric patients with disorders of the brain-gut interactions (DBGI) with no detectable gut inflammation.

What is being tested

• Esophagogastroduodenoscopy (EGD) with biopsy (diagnostic test)
• Colonoscopy w/ biopsy (diagnostic test)

Sponsor: Seattle Children's Hospital · Participants: 200 · Started: May 10, 2024

Contact the study team

• Mason E Nuding, BS · Phone: 206-987-0055

Official record on ClinicalTrials.gov — NCT06315179

Locations in the U.S.

Conditions

• Inflammatory Bowel Disease
• Crohn's Disease
• Ulcerative Colitis
• Esophagus Disorders

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.